Description
CJC-1295 with DAC 5MG
5mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
CJC-1295 with DAC 5mg (Drug Affinity Complex) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH). Unlike the “No DAC” version, this compound includes a Drug Affinity Complex that allows it to bind to serum albumin after administration. In research models, this significantly extends the half-life from minutes to several days, providing a continuous, non-pulsatile stimulation of the pituitary gland. Explore our full range of Research Peptides.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | CJC-1295 with DAC 5mg (GHRH Analog) |
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Malimide-beta-Ala)-NH2 |
| Molecular Formula | C165H269N47O46 |
| Molecular Weight | 3647.20 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 5 mg per vial |
| Grade | Laboratory Research Grade |
Research Application Areas
- Extended Half-Life Studies: Analysis of the Drug Affinity Complex (DAC) and its covalent bonding to albumin for prolonged bio-availability.
- Basal GH Elevation: Research into the steady-state elevation of Growth Hormone and IGF-1 levels rather than pulsatile release
- Metabolic Efficiency: Study of long-term impacts on adipose tissue lipolysis and nitrogen balance in metabolic models.
- Tissue Regeneration: Investigation into the systemic effects of sustained GHRH agonism on skin, bone, and organ health.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
